Condition
Conduction Disorder
Total Trials
5
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Active Not Recruiting1
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06857201Not ApplicableWithdrawn
RAFT-TAVR PACE: LBBAP vs. RVP Post-TAVR in Patients Requiring PPI
NCT06620237Not ApplicableActive Not Recruiting
BIO|MASTER.CSP Study
NCT07201363Recruiting
Biomarkers of Inflammation and Fibrosis in Conduction Disorders After TAVI
NCT06371846RecruitingPrimary
Comparative Study of the Surface Electrocardiogram Signals During the Implantation of Conduction System Pacing Devices
NCT04776642Recruiting
Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
Showing all 5 trials